Navigation Links
Ovalum Ltd. Announces Sales Launch of CiTop™ Product-Line in Europe
Date:7/9/2008

First sales for revolutionary CTO Crossing System after recent CE clearance Ovalum Ltd., a privately held Israeli medical device company, has announced today the launch of sales of its new CiTop™ Guidewire product-line for angiographic procedures in the peripheral vasculature. The devices are intended to assist in the treatment of chronic complete arterial blockage (CTO). These obstructions are hard to traverse and patients are therefore often referred to bypass surgery or limb amputation.

(PRWEB) July 9, 2008 -- Following the approval for CE Marking from the European Economic Area, Ovalum has initiated sales of the CiTop™ product line in Europe, with orders totaling over 400 devices up to date.

Ovalum is currently in negotiation with distributors all around Europe including Spain, Germany, Greece, Turkey, Switzerland, Netherlands, Ireland, Austria and former USSR countries. Ovalum has signed distribution agreements in Italy (Kardia srl) and Russia (Center of Perinatal Medicine).

Procedures have already been done by: Dr. Jaques Clerissi in Italy, Dr Gouvas Konstantinos in Greece, Dr Yakovlev Sergeyand in Russia and Dr. Alexander Belenky in Israel.

All procedures showed tremendous success and demonstrated the quality and uniqueness of the CiTop™ products in saving limbs from amputation.

Noam Shamay Ovalum`s CEO says: " It is a great joy to see the real fruits after years of hard work. The company and management team are all united at this launch effort and we know we are at the right track seeing week to week an increase in sales. The response from the market is unbelievable".

The CiTop(TM) Guidewire System has a patented micro tip mechanism that with a wave-like motion automatically advances within the occluded material. After crossing the occlusion, the device can be further used as a rail for further interventional devices. The system includes a 0.025" micro-catheter for extra support and an extension wire to exchange catheters. The CiTop™ product line also includes the 0.014" CoBra™ CTO Guidewires and the TraVerse™ Micro-catheter.

About Ovalum

Ovalum Ltd. was founded in March 2005 by Noam Shamay and Eitan Finkelstein. Located in Rabin Science Park Rehovot, Israel, OVALUM Ltd. develops, manufactures and markets breakthrough products for the minimally invasive cardiology and interventional radiology markets designed specifically for the most challenging arterial procedures

Ovalum Ltd. investors: Ziegler Meditech equity Partners LP and Smithfield Fiduciary LLC, represented by Eitan Machover (Director) and Pontifax LP represented by Tomer Kariv (Director).

CiTop™, CoBra™, TraVerse™ are all trademarks of Ovalum Ltd.

###


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related biology technology :

1. ULURU Inc. Announces Update on Recent Development
2. Sigma-Aldrich Announces Collaboration With Metahelix Life Sciences
3. Royalty Pharma Announces that James Reddoch, Ph.D., Joins Management Team
4. Beckman Coulter Announces Second Quarter 2008 Earnings to be Released on Friday, July 25, 2008, Before Market Opens
5. Telik Announces Publication of Diabetes Research in Bioorganic & Medicinal Chemistry Letters
6. PAREXEL Announces Date of Fourth Quarter and Fiscal Year 2008 Earnings Release and Conference Call
7. Favrille Announces Resolution of Debt Obligations and Plans for Maximizing Assets
8. Medarex Announces July 10 Live Webcast of R&D Day Event
9. SENOMYX ANNOUNCES EXTENSION OF DISCOVERY AND DEVELOPMENT COLLABORATION WITH CADBURY PLC
10. AMDL Announces Investor Relations Presentation Available on Website
11. Nabriva Therapeutics Announces Appointment of New CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... March 29, 2017 , ... ACEA Biosciences, a privately ... quarterly travel award to noteworthy scientists who will be presenting research using ACEA ... round of awards are being given to two postdoctoral fellows studying pathogen capture ...
(Date:3/29/2017)... , March 29, 2017 /PRNewswire/ - The University of ... Nordion, a business of Sterigenics International, and General Atomics ... been submitted to the U.S. Nuclear Regulatory Commission (NRC). ... production of molybdenum-99 (Mo-99). Once operational, production from this ... U.S. demand for Mo-99, which currently must be imported ...
(Date:3/28/2017)... Hong Kong (PRWEB) , ... March 28, 2017 ... ... has selected NetDimensions Learning to replace paper-based processes and enhance training plan management ... “We are very pleased to partner with the SHL Group to help improve ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... of the Modular Building Institute (MBI), an international modular trade organization, were awarded ... modular category for the Pagliuca Life Lab at Harvard University. The awards were ...
Breaking Biology Technology:
(Date:3/2/2017)... Summary This report provides all the information you ... activities since 2010. ... Read the full report: http://www.reportlinker.com/p03605615-summary/view-report.html ... an in-depth insight into the partnering activity of one of ... company reports are prepared upon purchase to ensure inclusion of ...
(Date:3/2/2017)... 2017 Australian stem cell and regenerative medicine ... signed an agreement with the Monash Lung Biology Network, ... Institute and Department of Pharmacology at Monash University, ... study to support the use of Cymerus™ mesenchymal stem ... Asthma is a chronic, long term lung condition ...
(Date:2/28/2017)... -- News solutions for biometrics, bag drop and New ... At ... 16 March, Materna will present its complete end-to-end passenger journey, ... a real benefit for passengers. To accelerate the whole passenger ... point solutions to take passengers through the complete integrated process ...
Breaking Biology News(10 mins):